Acute Leukemia

March 8, 2009

Novel Agent Appears Promising in the Treatment of Acute Lymphoid Leukemia

Charles H. Weaver, MD
March 8, 2009

PCR Test May Help Identify Persons at High Risk for Recurrence of ALL

Charles H. Weaver, MD
March 8, 2009

PKC 412 Promising for Acute Myeloid Leukemia

Charles H. Weaver, MD
March 8, 2009

Prediction of Outcomes of Pediatric Patients with Relapsed ALL

Charles H. Weaver, MD
March 8, 2009

Gene Clustering Helps to Classify Patients with AML

Charles H. Weaver, MD
March 8, 2009

Early Study Shows Promise in the Treatment of Acute Myeloid Leukemia

Charles H. Weaver, MD
March 8, 2009

Novel Treatment Improves Survival for Acute Leukemia Relapsing after Transplant

Charles H. Weaver, MD
March 8, 2009

Clolar™ Approved for Pediatric Acute Lymphoblastic Leukemia

Charles H. Weaver, MD
March 8, 2009

Gleevec® Shows Promise for the Treatment of Select Patients with ALL

Charles H. Weaver, MD
$CLAG-M Regimen Effective in Refractory Acute Myeloid Leukemia$

March 8, 2009

CLAG-M Regimen Effective in Refractory Acute Myeloid Leukemia

Charles H. Weaver, MD
March 8, 2009

Clolar® and Low-Dose Cytarabine May Be Effective in Elderly Patients with AML

Charles H. Weaver, MD
March 8, 2009

Tryptase May Help Predict Risk of Relapse in AML

Charles H. Weaver, MD